Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences: Chris Smith, David Meline

Chris Smith has been appointed to the board of directors of Pacific Biosciences, replacing David Meline, who resigned from the board. Smith is the CEO of oncology testing services firm NeoGenomics. Previously, he was chairman and CEO of Ortho Clinical Diagnostics, and before that, CEO of Cochlear. He holds a BS in journalism from Texas A&M University.